24. Uncovering Untreated Heart Disease With AI And Big Data: A Conversation With Egnite’s Joel Portice And Edwards Lifesciences’ Don Bobo The Venture podcast

Artwork

Innehåll tillhandahållet av Leap by McKinsey. Allt poddinnehåll inklusive avsnitt, grafik och podcastbeskrivningar laddas upp och tillhandahålls direkt av Leap by McKinsey eller deras podcastplattformspartner. Om du tror att någon använder ditt upphovsrättsskyddade verk utan din tillåtelse kan du följa processen som beskrivs här https://sv.player.fm/legal.

The Venture « »
24. Uncovering untreated heart disease with AI and big data: A conversation with egnite’s Joel Portice and Edwards Lifesciences’ Don Bobo

1+ y ago 33:23

Dela

MP3•Episod hem

Innehåll tillhandahållet av Leap by McKinsey. Allt poddinnehåll inklusive avsnitt, grafik och podcastbeskrivningar laddas upp och tillhandahålls direkt av Leap by McKinsey eller deras podcastplattformspartner. Om du tror att någon använder ditt upphovsrättsskyddade verk utan din tillåtelse kan du följa processen som beskrivs här https://sv.player.fm/legal.

Cardiovascular disease remains the number one killer in every developed country, but only one in ten US patients with severe heart ailments received treatment in 2022. Egnite, a healthcare start-up, has ambitious plans to dramatically improve treatment of heart disease by harnessing the power of AI and big data to identify patients who fell through the cracks after being diagnosed. Egnite was spun out from Edwards Lifesciences, a California-based medical technology company, in early 2021. Egnite’s digital platform, CardioCare, steadily gained acceptance among clinicians, physicians, and hospitals, as the industry rapidly adopted new technology during the pandemic. Don Bobo, corporate vice president at Edwards, and Joel Portice, president and CEO of egnite, sat down with McKinsey’s Andrew Roth to discuss the CardioCare platform, the relationship between egnite and Edwards, and the lifesaving capabilities of AI and big data.

See www.mckinsey.com/privacy-policy for privacy information

… continue reading

29 episoder

Artwork

24. Uncovering untreated heart disease with AI and big data: A conversation with egnite’s Joel Portice and Edwards Lifesciences’ Don Bobo

19 subscribers

published 1+ y ago

Dela

MP3•Episod hem

Innehåll tillhandahållet av Leap by McKinsey. Allt poddinnehåll inklusive avsnitt, grafik och podcastbeskrivningar laddas upp och tillhandahålls direkt av Leap by McKinsey eller deras podcastplattformspartner. Om du tror att någon använder ditt upphovsrättsskyddade verk utan din tillåtelse kan du följa processen som beskrivs här https://sv.player.fm/legal.

Cardiovascular disease remains the number one killer in every developed country, but only one in ten US patients with severe heart ailments received treatment in 2022. Egnite, a healthcare start-up, has ambitious plans to dramatically improve treatment of heart disease by harnessing the power of AI and big data to identify patients who fell through the cracks after being diagnosed. Egnite was spun out from Edwards Lifesciences, a California-based medical technology company, in early 2021. Egnite’s digital platform, CardioCare, steadily gained acceptance among clinicians, physicians, and hospitals, as the industry rapidly adopted new technology during the pandemic. Don Bobo, corporate vice president at Edwards, and Joel Portice, president and CEO of egnite, sat down with McKinsey’s Andrew Roth to discuss the CardioCare platform, the relationship between egnite and Edwards, and the lifesaving capabilities of AI and big data.

See www.mckinsey.com/privacy-policy for privacy information

… continue reading

29 episoder

सभी एपिसोड

×

Välkommen till Player FM

Player FM scannar webben för högkvalitativa podcasts för dig att njuta av nu direkt. Den är den bästa podcast-appen och den fungerar med Android, Iphone och webben. Bli medlem för att synka prenumerationer mellan enheter.

Lyssna på 500+ ämnen